iSpecimen Inc. Loss Contingency, Damages Paid, Value
iSpecimen Inc. (ISPC) reported Loss Contingency, Damages Paid, Value of $586.80 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:LossContingencyDamagesPaidValue · last filed 2026-08-14
- iSpecimen Inc. loss contingency, damages paid, value for the quarter ending 2026-06-30 was $0.00.
- iSpecimen Inc. loss contingency, damages paid, value for the quarter ending 2026-03-31 was $586.80K, a 0.00% change year-over-year.
- iSpecimen Inc. loss contingency, damages paid, value for the quarter ending 2025-12-31 was $0.00.
- iSpecimen Inc. loss contingency, damages paid, value for the quarter ending 2025-09-30 was $0.00.
- iSpecimen Inc. loss contingency, damages paid, value for fiscal 2025 was $586.80K, a 0.00% change from fiscal 2024.
- iSpecimen Inc. loss contingency, damages paid, value for fiscal 2024 was $586.80K.
| Period end | Loss Contingency, Damages Paid, Value | Loss Contingency, Damages Paid, Value 3 month | Loss Contingency, Damages Paid, Value 6 month | Loss Contingency, Damages Paid, Value 9 month | Loss Contingency, Damages Paid, Value 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $586.80K 10-Q · filed 2026-08-14 | $586.80K derived: sum of 3 quarters · filed 2026-08-14 | $586.80K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2026-03-31 | $586.80K 10-Q · filed 2026-05-18 | $586.80K derived: sum of 2 quarters · filed 2026-05-18 | $586.80K derived: sum of 3 quarters · filed 2026-05-18 | $586.80K derived: sum of 4 quarters · filed 2026-05-18 | |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | $0.00 derived: sum of 2 quarters · filed 2026-04-01 | $0.00 derived: sum of 3 quarters · filed 2026-04-01 | $586.80K 10-K · filed 2026-04-01 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-17 | $0.00 derived: sum of 2 quarters · filed 2025-11-17 | $586.80K 10-Q · filed 2025-11-17 | ||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $586.80K 10-Q · filed 2025-08-14 | |||
| 2025-03-31 | $586.80K 10-Q · filed 2025-05-19 | ||||
| 2024-12-31 | $586.80K 10-K · filed 2025-04-14 | ||||
| 2024-12-09 | $489.57K 10-Q · filed 2026-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |